Description:BMS-911543, with the CAS number 1271022-90-2, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in the context of cancer. It acts as a selective inhibitor of certain protein kinases, which are crucial in regulating cellular processes such as growth, proliferation, and survival. The compound's mechanism of action typically involves the modulation of signaling pathways that are often dysregulated in cancer cells. BMS-911543 has shown promise in preclinical studies, demonstrating efficacy in inhibiting tumor growth and enhancing the effects of other therapeutic agents. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. As with many investigational drugs, ongoing research is necessary to fully understand its safety profile, optimal dosing regimens, and potential side effects. Overall, BMS-911543 represents a significant area of interest in the field of targeted cancer therapy.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.